AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 61 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $32,533,000 | +25.5% | 3,952,957 | 0.0% | 1.62% | +21.9% |
| Q2 2022 | $25,931,000 | +17.4% | 3,952,957 | 0.0% | 1.33% | +108.8% |
| Q1 2022 | $22,097,000 | +19.2% | 3,952,957 | -0.0% | 0.64% | +70.1% |
| Q4 2021 | $18,539,000 | -24.1% | 3,952,958 | 0.0% | 0.38% | +29.3% |
| Q3 2021 | $24,429,000 | -6.2% | 3,952,958 | 0.0% | 0.29% | -14.5% |
| Q2 2021 | $26,050,000 | -10.0% | 3,952,958 | 0.0% | 0.34% | -47.8% |
| Q1 2021 | $28,936,000 | +26.9% | 3,952,958 | 0.0% | 0.65% | +7.8% |
| Q4 2020 | $22,809,000 | -2.9% | 3,952,958 | 0.0% | 0.60% | -39.4% |
| Q3 2020 | $23,481,000 | +15.3% | 3,952,958 | 0.0% | 0.99% | +21.5% |
| Q2 2020 | $20,358,000 | +122.8% | 3,952,958 | +56.6% | 0.82% | +71.5% |
| Q1 2020 | $9,138,000 | – | 2,524,387 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 2,739,255 | $22,544,000 | 7.01% |
| Worth Venture Partners, LLC | 685,026 | $5,638,000 | 3.45% |
| NEA Management Company, LLC | 3,952,957 | $32,533,000 | 1.62% |
| Birchview Capital, LP | 140,000 | $1,152,000 | 0.81% |
| Rubric Capital Management LP | 1,664,667 | $13,700,000 | 0.69% |
| EAM Investors, LLC | 380,691 | $3,133,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 368,520 | $3,033,000 | 0.52% |
| X-Square Capital, LLC | 92,283 | $759,000 | 0.48% |
| EAM Global Investors LLC | 211,759 | $1,743,000 | 0.46% |
| J. Goldman & Co LP | 656,161 | $5,400,000 | 0.26% |